A large number of clinical trials showed that candesartan could reduce the cardiovascular mortality for heart failure an大量临床研究结果表明坎地沙坦可降低心力衰竭病人心血管死亡率和因心力衰竭加重的住院率。
Candesartan is a highly selective angiotensin Ⅱ type Ⅰ receptor blocker, mainly used in the treatment of hypertension an摘要坎地沙坦是一个高选择性血管紧张肽Ⅱ受体Ⅰ拮抗药，主要用于高血压和心力衰竭的治疗。